Immucell Corp (ICCC): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Immucell Corp (ICCC) following the 2026 Q1 hedge fund 13F filings?

As of today, ICCC has moved +14.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -677.0%. Since the quarter end (March 31, 2026), ICCC gained +49.9% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Immucell Corp (ICCC)

27 + Investors. Track Smart Money conviction in ICCC. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ICCC

Based on 27 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added ICCC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

📊

High ownership — 90% of 3.0Y peak

90% of all-time peak

27 funds currently hold this stock — 90% of the 3.0-year high of 30 funds (reached 2023 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q

+1 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 60% buying

12 buying8 selling

Last quarter: 12 funds were net buyers (5 opened a brand new position + 7 added to an existing one). Only 8 were sellers (4 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~5 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 2 → 3 → 3 → 5. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

56% of holders stayed for 2+ years

■ 56% conviction (2yr+) ■ 22% medium ■ 22% new

15 out of 27 hedge funds have held ICCC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

➡️

Steady discovery — ~5 new funds/quarter

1 → 2 → 3 → 3 → 5 new funds/Q

New funds entering each quarter: 2 → 3 → 3 → 5. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 63% veterans vs 22% newcomers

■ 63% veterans ■ 15% 1-2yr ■ 22% new

Entry-cohort mix of 27 holders: 17 (63%) are 2+ year veterans, 4 entered 1–2 years ago, and 6 (22%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds

8 of 27 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.2

out of 10

Low Exit Risk

Exit risk score 3.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	27	26	3.85%
13F Shares	1M	1M	6.97%
Total Value	$9M	$8M	10.04%
New Positions	5	3	+2
Increased Positions	7	8	-1
Closed Positions	4	2	+2
Reduced Positions	4	6	-2
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

3.85%

13F Shares

6.97%

Total Value

$9M

$8M

10.04%

New Positions

Increased Positions

-1

Closed Positions

Reduced Positions

-2

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

27 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ICCC. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 23 ICCC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Steadtrust LLC	0.20%	54,370	$344K
2	Bleichroeder LP	0.11%	101,594	$643K
3	Militia Capital Management LLC	0.03%	18,000	$114K
4	Shufro Rose & Co LLC	0.02%	35,000	$222K
5	Strategic Financial Services, Inc.	0.01%	37,000	$234K
6	Mesirow Financial Investment Management, Inc.	0.00%	42,481	$269K
7	Essex Financial Services, Inc.	0.00%	11,000	$70K
8	Cresset Asset Management, LLC	0.00%	135,267	$856K
9	Renaissance Technologies LLC	0.00%	151,789	$961K
10	Bailard, INC.	0.00%	10,102	$64K
11	Hm Payson & Co	0.00%	4,000	$25K
12	HighTower Advisors, LLC	0.00%	24,354	$154K
13	Morgan Stanley	0.00%	221,716	$1.4M
14	Vanguard Fiduciary Trust Co	0.00%	42,669	$270K
15	Vanguard Capital Management LLC	0.00%	260,327	$1.6M
16	Citadel Advisors LLC	0.00%	35,696	$226K
17	Harbour Investments, INC.	0.00%	250	$2K
18	Advisory Services Network, LLC	0.00%	200	$1K
19	Osaic Holdings, INC.	0.00%	391	$2K
20	BlackRock, Inc.	0.00%	18,186	$115K
21	UBS Group AG	0.00%	1,113	$7K
22	Jones Financial Companies Lllp	0.00%	19	—
23	Wells Fargo & Company/Mn	0.00%	1	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Immucell Corp (ICCC)

What does the Smart Money Trend signal show for ICCC?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ICCC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ICCC?

More buyers than sellers — 60% buying: Last quarter: 12 funds were net buyers (5 opened a brand new position + 7 added to an existing one). Only 8 were sellers (4 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ICCC holders?

Strong quality — 31% AUM from major funds: 8 of 27 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ICCC?

56% of holders stayed for 2+ years: 15 out of 27 hedge funds have held ICCC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Immucell Corp (ICCC) following the 2026 Q1 hedge fund 13F filings?

As of today, ICCC has moved +14.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -677.0%. Since the quarter end (March 31, 2026), ICCC has gained +49.9% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Immucell Corp (ICCC)

Smart Money Signals — ICCC

Buying streak — 3 quarters in a row

High ownership — 90% of 3.0Y peak

Steady growth — +4% more funds vs a year ago

More buyers than sellers — 60% buying

Steady new buyers — ~5 new funds per quarter

56% of holders stayed for 2+ years

Steady discovery — ~5 new funds/quarter

Veteran-anchored — 63% veterans vs 22% newcomers

Strong quality — 31% AUM from major funds

Institutional Sentiment Summary — ICCC

Hedge Fund Ownership: ICCC

Market Analysis: ICCC

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ICCC

Is It Too Late to Buy Immucell Corp (ICCC) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ICCC

Statistics: ICCC

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Immucell Corp (ICCC)

Welcome to 13Foresight!